Carisma Therapeutics (CARM) Earnings Date, Estimates & Call Transcripts $0.18 +0.01 (+4.60%) As of 03:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Carisma Therapeutics Earnings Summary Carisma Therapeutics announced Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.22, which missed the consensus estimate of -$0.17 by $0.05. Quarterly revenue was reported to be $3.65 million, above analyst estimates of $2.47 million. With a trailing EPS of -$1.56, Carisma Therapeutics' earnings are expected to grow next year, from ($1.32) to ($1.26) per share. Upcoming Q2 Earnings DateAug. 6Before Market OpensEstimatedConsensus EPS (May. 13) -$0.17 Actual EPS (May. 13) -$0.22 Missed By -$0.05 Actual Revenue (May. 13) $3.65MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q)CARM Upcoming EarningsCarisma Therapeutics' next earnings date is estimated for Wednesday, August 6, 2025, based on past reporting schedules. Powered by Get Carisma Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Carisma Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCARM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CARM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Carisma Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.48-$0.28-$0.38Q2 20252-$0.50-$0.27-$0.39Q3 20252-$0.54-$0.22-$0.38Q4 20251-$0.56-$0.56-$0.56 Carisma Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/6/2025(Estimated)--------5/13/2025Q1 2025-$0.17-$0.22 -$0.05-$0.22$2.47M$3.65M11/7/2024Q3 2024-$0.31-$0.31--$0.31-$3.39M8/8/2024--$0.36-$0.27+$0.09-$0.27$3.65M$9.20M5/9/2024Q1 2024-$0.37-$0.46 -$0.09-$0.46$3.90M$3.40M4/1/2024Q4 2023--$0.52 -$0.52-$0.52$4.00M$4.29M11/9/2023Q3 2023-$0.60-$0.53+$0.07-$0.53-$3.83M8/10/2023Q2 2023-$0.66-$0.49+$0.17-$0.49-$3.56M Carisma Therapeutics Earnings - Frequently Asked Questions When is Carisma Therapeutics's earnings date? Carisma Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 6th, 2025 based off last year's report dates. Learn more on CARM's earnings history. Did Carisma Therapeutics beat their earnings estimates last quarter? In the previous quarter, Carisma Therapeutics (NASDAQ:CARM) missed the analysts' consensus estimate of ($0.17) by $0.05 with a reported earnings per share (EPS) of ($0.22). Learn more on analysts' earnings estimate vs. CARM's actual earnings. How much revenue does Carisma Therapeutics generate each year? Carisma Therapeutics (NASDAQ:CARM) has a recorded annual revenue of $19.63 million. How much profit does Carisma Therapeutics generate each year? Carisma Therapeutics (NASDAQ:CARM) has a recorded net income of -$86.88 million. CARM has generated -$1.56 earnings per share over the last four quarters. What is Carisma Therapeutics's EPS forecast for next year? Carisma Therapeutics's earnings are expected to grow from ($1.32) per share to ($1.26) per share in the next year. More Earnings Resources from MarketBeat Related Companies BLUE Earnings Results KZR Earnings Results FGEN Earnings Results MRNS Earnings Results INKT Earnings Results ALLK Earnings Results SCLX Earnings Results CALC Earnings Results GRCE Earnings Results SRZN Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:CARM) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carisma Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carisma Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
